Caspase-9 upregulation has been associated with the progression of myopathy in slow-channel syndrome (SCS, a myasthenic disorder caused by mutations in acetylcholine receptors) and in intervertebral disk degeneration in lumbar disc disease (LDD) (Table 4). This evidence concerns the gene CASP9 and lumbar disk degenerative disorder.